CRP and familial pancreatic carcinoma: Many diagnostic biosensing devices have been proposed for the detection of biomarkers in complex body fluids like blood, saliva, or urine, such as troponin and creatine kinase as indicators for myocardial infarction [287], C-reactive protein (CRP), and P-selectin for ischemic stroke, CA 19-9 and B-type natriuretic peptide (BNP) for pancreatic cancer or pro-inflammatory cytokines and chemokines, to list a few.